G蛋白激动剂与一氧化氮/环鸟苷酸阻断剂：制药行业中未被探索的前沿领域。 - Suppr

G-Proteins Agonists and NO/cGMP Blockers: Unexplored Frontiers in the Pharmaceutical Industry.

作者信息

Evora Paulo Roberto B

机构信息

Departamento de Cirurgia e Anatomia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, São Paulo, SP, Brazil.

出版信息

Arq Bras Cardiol. 2017 Oct;109(4):275-276. doi: 10.5935/abc.20170139.

DOI:10.5935/abc.20170139

PMID:29069206

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5644205/

Abstract

摘要

相似文献

G-Proteins Agonists and NO/cGMP Blockers: Unexplored Frontiers in the Pharmaceutical Industry.

Arq Bras Cardiol. 2017 Oct;109(4):275-276. doi: 10.5935/abc.20170139.

Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment.

Crit Care. 2018 Apr 20;22(1):104. doi: 10.1186/s13054-018-2024-y.

Vitamin B12 for the treatment of vasoplegia in cardiac surgery and liver transplantation: a narrative review of cases and potential biochemical mechanisms.

Can J Anaesth. 2019 Dec;66(12):1501-1513. doi: 10.1007/s12630-019-01449-x. Epub 2019 Jul 25.

Anxiolytic effects induced by inhibition of the nitric oxide-cGMP pathway in the rat dorsal hippocampus.

Psychopharmacology (Berl). 2007 Dec;195(2):183-92. doi: 10.1007/s00213-007-0890-0. Epub 2007 Jul 28.

Hydroxocobalamin for the Treatment of Vasoplegia: A Review of Current Literature and Considerations for Use.

J Cardiothorac Vasc Anesth. 2019 Apr;33(4):894-901. doi: 10.1053/j.jvca.2018.08.017. Epub 2018 Aug 11.

Vasoplegia in septic shock: do we really fight the right enemy?

J Crit Care. 2014 Feb;29(1):83-7. doi: 10.1016/j.jcrc.2013.08.021. Epub 2013 Oct 4.

Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.

Cardiovasc Res. 1996 Sep;32(3):622-9.

The nitric oxide-cyclic GMP-protein kinase G-K+ channel pathway participates in the antiallodynic effect of spinal gabapentin.

Eur J Pharmacol. 2006 Feb 15;531(1-3):87-95. doi: 10.1016/j.ejphar.2005.12.006. Epub 2006 Jan 24.

Relation of cyclic guanosine monophosphate and cyclic adenosine monophosphate in reducing the toxic effects of protamine administration.

J Thorac Cardiovasc Surg. 1997 Mar;113(3):617. doi: 10.1016/S0022-5223(97)70385-4.

Targeting CD47: NO limit on therapeutic potential.

Circ Res. 2007 Mar 16;100(5):602-3. doi: 10.1161/01.RES.0000261609.44977.25.

引用本文的文献

Ischemia/Reperfusion Injury Revisited: An Overview of the Latest Pharmacological Strategies.

Int J Mol Sci. 2019 Oct 11;20(20):5034. doi: 10.3390/ijms20205034.

Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment.

Crit Care. 2018 Apr 20;22(1):104. doi: 10.1186/s13054-018-2024-y.

本文引用的文献

Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised.

Rev Bras Cir Cardiovasc. 2015 Jan-Mar;30(1):84-92. doi: 10.5935/1678-9741.20140115.

Methylene blue for vasoplegic syndrome treatment in heart surgery: fifteen years of questions, answers, doubts and certainties.

Rev Bras Cir Cardiovasc. 2009 Jul-Sep;24(3):279-88. doi: 10.1590/s0102-76382009000400005.

Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue.

Ann Allergy Asthma Immunol. 2007 Oct;99(4):306-13. doi: 10.1016/S1081-1206(10)60545-5.

The concept of crosstalk and its implications for cardiovascular function and disease.

Arq Bras Cardiol. 2007 Jan;88(1):e26-31. doi: 10.1590/s0066-782x2007000100029.

Is the cyclic GMP system underestimated by intensive care and emergency teams?

Med Hypotheses. 2007;69(3):564-7. doi: 10.1016/j.mehy.2007.01.041. Epub 2007 Mar 23.

The role of G-proteins in the pathophysiology of the cardiovascular diseases.

Arq Bras Cardiol. 1999 Feb;72(2):209-29. doi: 10.1590/s0066-782x1999000200009.

Impaired endothelium-dependent relaxation after coronary reperfusion injury: evidence for G-protein dysfunction.

Ann Thorac Surg. 1994 Jun;57(6):1550-6. doi: 10.1016/0003-4975(94)90121-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

G-Proteins Agonists and NO/cGMP Blockers: Unexplored Frontiers in the Pharmaceutical Industry.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献